User:Mr. Ibrahem/Minimal change disease

From Wikipedia, the free encyclopedia
Minimal change disease
Other namesMinimal change glomerulopathy, minimal change nephrotic syndrome, nil disease, lipoid nephrosis[1][2]
The three hallmarks of minimal change disease seen on electron microscopy: diffuse loss of podocyte foot processes, vacuolation, and the appearance of microvilli.
SpecialtyNephrology
SymptomsSwelling, foamy urine[1]
ComplicationsBlood clots, infections, high cholesterol[1]
Usual onset2 to 3 years old[3]
CausesUnknown[1]
Diagnostic methodGenerally based on symptoms, labs, and urine testing[2]
Differential diagnosisGlomerulonephritis, heart failure, lymphedema[2]
TreatmentCorticosteroids, blood pressure medication[4]
PrognosisGenerally good[2]
Frequency1 in 20,000 children per year[2]

Minimal change disease (MCD) is a kidney disease with significant protein in the urine but a relatively normal kidney biopsy when examined by a light microscope.[4] Symptoms include swelling and foamy urine.[1] Complications can include blood clots, infections, dehydration, and high cholesterol.[1][2] Kidney failure is rare.[1]

The cause is generally unknown.[1][2] It may be triggered by an infection or allergic reaction.[1] The underlying mechanism involves damage to the glomeruli.[1] Diagnosis is generally based on symptoms together with urine and lab tests.[2] If the diagnosis is unclear a kidney biopsy may be useful.[2]

Treatment may include corticosteroids, cyclophosphamide, or cyclosporine.[4] High blood pressure may be managed with an ACE inhibitor or calcium channel blocker.[1] A low salt diet and a diuretic may be used to control swelling.[4] Outcomes are generally good in all age groups.[2] In more than 80% of adults, the disease resolves with treatment.[1]

About 1 in 20,000 children are affected a year.[2] It is most common in those around the age of 2 to 3 years old.[3] In children males are more commonly affected than females.[2] It is uncommon in adults.[2] It is the most common cause of nephrotic syndrome in children, and responsible for 10 to 25% of cases in adults.[1][5] The disease was first described by Munk in 1913.[6]

References[edit]

  1. ^ a b c d e f g h i j k l m "Minimal change disease | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 24 January 2021.
  2. ^ a b c d e f g h i j k l m Zamora, G; Pearson-Shaver, AL (January 2020). "Minimal Change Disease". PMID 32809474. {{cite journal}}: Cite journal requires |journal= (help)
  3. ^ a b Cheung, Alfred K. (2005). Primer on Kidney Diseases. Elsevier Health Sciences. p. 165. ISBN 978-1-4160-2312-8.
  4. ^ a b c d "Glomerular Diseases | NIDDK". National Institute of Diabetes and Digestive and Kidney Diseases. Retrieved 24 January 2021.
  5. ^ Hogan J, Radhakrishnan J (April 2013). "The treatment of minimal change disease in adults". Journal of the American Society of Nephrology. 24 (5): 702–11. doi:10.1681/ASN.2012070734. PMID 23431071.
  6. ^ Yu, Alan S. L.; Chertow, Glenn M.; Luyckx, Valerie; Marsden, Philip A.; Skorecki, Karl; Taal, Maarten W. (2015). Brenner and Rector's The Kidney E-Book. Elsevier Health Sciences. p. 1016. ISBN 978-0-323-26259-0.